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Abstract
Protein palmitoylation has emerged as an important mechanism for regulating protein trafficking, stability, and protein–
protein interactions; however, its relevance to disease processes is not clear. Using a genome-wide, phenotype driven N-
ethyl-N-nitrosourea–mediated mutagenesis screen, we identified mice with failure to thrive, shortened life span, skin and
hair abnormalities including alopecia, severe osteoporosis, and systemic amyloidosis (both AA and AL amyloids
depositions). Whole-genome homozygosity mapping with 295 SNP markers and fine mapping with an additional 50 SNPs
localized the disease gene to chromosome 7 between 53.9 and 56.3 Mb. A nonsense mutation (c.1273A.T) was located in
exon 12 of the Zdhhc13 gene (Zinc finger, DHHC domain containing 13), a gene coding for palmitoyl transferase. The
mutation predicted a truncated protein (R425X), and real-time PCR showed markedly reduced Zdhhc13 mRNA. A second
gene trap allele of Zdhhc13 has the same phenotypes, suggesting that this is a loss of function allele. This is the first report
that palmitoyl transferase deficiency causes a severe phenotype, and it establishes a direct link between protein
palmitoylation and regulation of diverse physiologic functions where its absence can result in profound disease pathology.
This mouse model can be used to investigate mechanisms where improper palmitoylation leads to disease processes and to
understand molecular mechanisms underlying human alopecia, osteoporosis, and amyloidosis and many other
neurodegenerative diseases caused by protein misfolding and amyloidosis.
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Introduction
Proteins can be modified by a variety of lipids, including myristate
(C14), farnesyl (C15), palmitate (C16), geranylgeranyl (C20) and
glycosylphosphatidylinositol (GPI). Palmitoylation is one of the most
common post-translational lipid modifications that involve the
addition of palmitate to specific cysteine residues of proteins via a
thioester linkage [1–3]. Although most of the lipid modifications are
irreversible, protein S-palmitoylation can be either permanent or
transient, which allows it to dynamically regulate protein function
[1,4]. Numerous soluble and integral membrane proteins have been
shown to be palmitoylated including signaling proteins, enzymes,
scaffolding proteins, ion channels, cell adhesion molecules and
neuronal proteins. Specific examples are oncogenic Ras proteins,
trimeric G protein a subunit, Rap2b, RhoB, eNOS, SNAP-25, PSD-
95 postsynaptic scaffolding protein, huntingtin and anthrax toxin
receptor [1,2,5–8].
Palmitoyl post-translational modification has recently emerged
as an important mechanism for modulating protein targeting,
trafficking, stability and protein-protein interactions, and plays
roles in numerous cellular processes, including signaling, apoptosis
and neuronal transmission [1,3].
Although palmitoylation was first described over 30 years ago,
the genes coding for enzymes involved in protein palmitoylation,
the palmitoyl acyltransferase (PATs), have only recently been
discovered [7,9]. To date, at least 23 members of PATs have been
identified in the mammalian genome [9,10]. This family of
proteins contains a cysteine-rich domain (CRD) with a core Asp-
His-His-Cys (DHHC) motif that is essential for PAT activity
[7,9,11]. The presence of so many PATs in a single organism
PLoS Genetics | www.plosgenetics.org 1 June 2010 | Volume 6 | Issue 6 | e1000985could be due to differences in substrate specificities, intracellular
localizations or tissue distributions. For example, DHHC2 and
DHHC15 are more specific to PSD-95 and GAP-43, DHHC9 and
DHHC18 are specific to H-Ras and N-Ras, while DHHC3 and
the closely related DHHC7 have broad substrate specificities [2,8].
In neuronal tissue, DHHC13 and 17 modulate huntingtin
palmitoylation and DHHC8 modulates paralemmin-1 [11]. The
substrate specificity appears to be determined by the regulatory
domains outside the DHHC domains of the enzymes [8,11].
Despite the functional importance of protein palmitoylation at
the cellular and biochemical levels, its physiological role and its
relevance to disease processes is not clear. Oncogenic Ras proteins
and huntingtin are direct targets for palmitoylation thus, they may
be involved in the disease process. Disregulation of DHHC2 may
be involved in cancer metastasis [12]. The sole mouse model of
DHHC deficiency is the Zdhhc8 knockout; these mice have a mild
behavior phenotype with a decrease in exploratory activity and a
deficiency in prepulse inhibition. These behavioral changes are
only observed in female mice. The phenotypes together with
genetic evidence may support the hypothesis that DHHC8 is a risk
factor for schizophrenia [13]. Systematic knockdown of the Zdhhc
genes has not been done, which could provide some unexpected
physiological roles for DHHC proteins. Here we report on mice
with a mutation in the Zdhhc13, a gene coding for palmitoyl
acyltransferase, which catalyzes the reaction of protein palmitoyla-
tion [11]. Mutant mice exhibit a severe phenotype and profound
pathology involving multi-organ/systems. These mice, developed
cachexia, alopecia, osteoporosis, systemic amyloidosis, failed to
thrive and succumbed to early death.
Results
The mutant mice were analyzed either on a C57BL/66129S6/
SvEv or C57BL/66129S6/SvEv 6 C3H mixed genetic back-
ground. The phenotypes described herein are all penetrant in both
genetic backgrounds.
Clinical Phenotypes
General appearance. Affected mice appeared normal at
birth, but by postnatal day 7 were small in size and developed
hypotrichosis; these features differentiated affected from normal
siblings. The affected male mice had poor weight gain and
weighed 50% less than the unaffected siblings (Figure 1A). Affected
females mice also showed similar poor weight gain (data not
shown). In addition, these mice, regardless of sex, had a shortened
life span; about 50% died before 7.5 months of age and only 20%
survived beyond one year of age (Figure 1B). Furthermore, the
affected mice showed generalized hypotrichosis and hair loss
particularly certain body parts, some hairs remained over the head
and back, although, they were thin, short and had decreased luster
(Figure 2). Skin was loose with wrinkling and folding (Figure 2C).
Kyphosis was evident beginning at day 28 (Figure 2, also shown in
Figure 3A). When the gene responsible for these phenotypes was
identified as Zhddc13 (see below under Identification of the
mutated gene), it was clear that only homozygous Zdhhc13 -/-
Author Summary
Palmitoylation, the addition of palmitate (a fatty acid) to
protein, is one of the most common post-translational lipid
modifications and has recently emerged as an important
mechanism for modulating protein targeting, trafficking,
stability, and protein–protein interactions. However, its
physiological role and its relevance to the disease
processes are not at all clear. Here we reported that mice
with mutation in Zdhhc13, a gene coding for palmitoyl
acyltransferase that catalyzes the reaction of protein
palmitoylation, exhibited a severe phenotype and pro-
found pathology involving multi-organ/systems. These
mice showed wasting, weight loss, hair loss (alopecia),
reduced bone mineral density (osteoporosis), and gener-
alized amyloid deposition, which resulted in early death.
Our results established a direct link between protein
palmitoylation and regulation of the important diverse
physiological functions and indicated that its absence can
result in profound disease pathology. This mouse model
will be useful for further understanding the molecular
mechanisms underlying human alopecia, osteoporosis,
and many other neurodegenerative diseases caused by
protein misfolding and amyloid deposition.
Figure 1. Body weight and life span of the affected mice. (A) Body weights of affected male mice compared to their unaffected male siblings
(n=10 each). Values are expressed as mean 6 SE. (B) Life span of the affected mice compared to their unaffected siblings (n=10 each).
doi:10.1371/journal.pgen.1000985.g001
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displayed normalcy like the wild-type (+/+).
Hematology and blood chemistry. Complete blood counts
obtained from affected mice at 4 weeks and 30 weeks of age were
comparable to the wild-type, except that adult mutant mice showed
neutrophilia (mutant=58.862.24 and unaffected=38.564.13,
P,0.05) and lymphocytopenia (mutant=33.161.86 and
53.864.88 unaffected) despite normal WBC counts (Table S1).
Blood biochemistry revealed elevations in AST and ALT enzymes in
the adult (ALT in mutant=100.6615.3 and in unaffected=
52.865.07, AST in mutant=44.567.18 and in unaffected=
24.862.72, P,0.05). However, at 4 weeks of age only AST was
elevated (mutant=101.6615.6 and unaffected=56.463.09,
P,0.05) (Table S2). About 10% of adult mice also showed
Figure 2. General appearance of the affected mice. Note the size difference of affected versus unaffected sibling (A). Affected mice at different
ages, 4 weeks (B), kyphosis with sharper spine angle in affected mouse and patchy alopecia (C), at 6 months of age (D) and just before death at 7.5
months of age (E).
doi:10.1371/journal.pgen.1000985.g002
Figure 3. Skeletal abnormalities in the affected mice. (A) Radiographs of affected mouse and unaffected sibling at 26 weeks of age. Yellow
bars indicate the position of spine. Scale bar=1 cm. (B) Micro–CT imaging of the femur trabecular bone in the wild-type and skcm
04Jus mice taken at
26 weeks of age. The 3D images of trabecular bone were reconstructed as described in Materials and Methods; scale bar=1 cm.
doi:10.1371/journal.pgen.1000985.g003
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calcium, magnesium and C-reactive protein were all within normal
limits in the affected mice at both 4 weeks and 30 weeks of age.
Bone studies. Radiographic examinations showed severe
kyphosis with marked increased spinal angle in the affected mice
(Figure 3A). Osteoporosis was also profound, as evidenced by a
decrease in the trabecular number of femur (Figure 3B and
Table 1) and by other trabecular bone parameters, including a
decrease in bone volume density (BV/TV) and bone mineral
density (BMD), along with an increase in the structure model
index (SMI), which indicated an abundance of rod-like trabeculae
(Table 1). These features of osteoporosis could be seen as early as 4
weeks of age (data not shown).
Histopathological analyses. Post mortem examinations
revealed hepatosplenomegaly (2-3 times normal), severe muscle
wasting and reduced white and brown adipose tissue. Skin
histopathology of the affected mice showed hyperkeratosis and
epidermis hyperplasia with thin dermis and scanty adipose tissue
(Figure 4A). Hair follicles in different stages, such as anagen, catagen,
and telogen, could be observed in wild-type mice (Figure 4D), while
mutant mice had significantly fewer active hair follicles with most
remaining in the late telogen phase. There were no hair shafts in the
affected hair follicles and the upper portion was dilated (Figure 4C).
Amyloid deposition was observed in the entire dermis in the affected
mice as homogenous eosinophilic substances by H&E stain
(Figure 5A). This was confirmed by Congo red stain as pink-red
deposits (Figure 5B) and under a polarizing microscope as yellow-
green birefringence (Figure 5C).
Amyloid depositions were also found in most of the other major
organs examined, except for muscle. Amyloids were seen in liver,
spleen, kidney, adrenal gland, pancreas, salivary glands, heart,
lung, intestine and brain. The amyloids deposited in organs and
their severity in young (4 weeks) and older animals (20–32 weeks)
are summarized in Table 2. In general, there was a progressive
increase of amyloid with age.
In the liver, amyloid deposits were observed mainly in sinusoids
around perivascular areas (Portal and central veins) (Figure 6A).
Enlarged Kupffer cells containing amyloid substance were also
seen and in severe cases, massive amyloid deposits disrupted the
hepatic architecture (data not shown). Mild amyloid deposition in
the space of Disse or sinusoid was also found in young mice as
early as 4 weeks of age (Table 2).
In the spleen, accumulations of amyloid appeared in peri-white
pulp, connective tissue frameworks of red pulp and central arterial
walls of white pulp (Figure 6B). Mild amyloid deposition was also
observed in young animals; however, the arterial wall findings
were not detectable in young mutants (Table 2).
In the kidney, amyloid accumulated in the glomerulus (Figure 6C),
renal tubules (Figure 6D) and perivascular areas. Thickenings of the
basement membranes of glomerular capillaries and mesangial matrix
were common lesions in mutants. In the advanced stage, the
glomerular capillaries were obliterated, and the glomerular structures
were completely destroyed. The renal tubules became dilated with
large amounts of filtrated substances (as an eosinophilic substance,
presumably albumin that is observed as a result of a glomerular
filtration defect) and some tubular epithelial cells showed atrophy. In
young animals, renal amyloidosis was milder, but could be seen in
both glomerulus and tubules (Table 2).
Massive amyloid deposits were also observed in the adrenal
glands in adult mice. Amyloid accumulated in the zona fasciculate,
zona reticularis, and in part of the zona glomerulosa and medulla
(Figure 6E).
In the pancreas, amyloid accumulated in both exocrine
pancreatic tissues and islet of Langerhans (Figure 6F) and, in the
advanced stage, acinar cells were degenerated and completely
replaced by amyloid. Acinar cells in salivary glands were also full
of amyloid (Figure 6G).
In the heart, amyloid deposition could be seen in the blood
vessel walls, and only in severe cases, amyloid was observed in the
myocardium (Figure 6H). Small amounts of amyloid deposits
could also been found in other organs such as lung, intestine and
brain. No amyloid deposition was found in skeletal muscle.
Immunohistochemistry Staining
Immunohistochemistry staining was performed using anti-
amyloid A, anti-kappa light chain and anti-lambda light chain to
confirm the amyloidosis and to differentiate AA and AL type of
amyloidosis. In liver, amyloid AA and AL k were the major
amyloid detected, primarily in sinusoids and around the portal
vein, while the amount of AL l amyloid was less (Figure 7, upper
panel). A similar pattern was also observed in kidney glomerulus
and tubular cells in which AA and AL k were the predominant
amyloids (Figure 7, lower panel). Both AA and AL k could also be
detected in the kidneys of the young animals (Table 2).
Identification of the Mutant Gene
To map the gene responsible for these abnormal phenotypes,
affected mice in the B66129 mix background were out-crossed to
C3H/HeJ mice to generate N1 (B6 and C3H hybrid) affected
offspring, then were intercrossed. The offspring of this intercross
(N1F1) were used in the genomic analysis. Whole genome SNP
homozygosity mapping revealed one region located between 46.4
a n d6 4 . 7 M b( 1 8 . 3 M b )o fc h r o m o s o m es e v e nw i t h9 0 %B 6
homozygosity in consecutive SNPs (Figure 8A). Fine mapping
narrowed down the candidate region to within 2.4 Mb (between
53.9 and 56.3 Mb) on chromosome 7 (Figure 8B). This region
contained 64 genes. Because our affected mice showed generalized
amyloidosis, we concentrated on the amyloid related genes located in
this region which included Saa1l (serum amyloid A-like 1), Saa3
(serum amyloid A 3), Saa4 (serum amyloid A 4), Saa1 (serum amyloid
A1 ) ,Saa2 (serum amyloid A 2) and Zdhhc13 (zinc finger, DHHC
domain containing 13). Direct DNA sequencing of genes in affected
m i c er e v e a l e dah o m o z y g o u sAt oTs u b s t i t u t i o ni ne x o n1 2o f
Zdhhc13 (c.1273A.T) (Figure 8C). The parents were heterozygous
for this mutation. Further study showed that the homozygous
c.1273A.T mutation (2/2)c o m p l e t e l ys e g r e g a t e dw i t ht h e
abnormal phenotypes. Siblings, as well as parents, that were
heterozygous for this mutation (+/2) were phenotypically normal.
This A to T substitution resulted in a stop codon (AGA.TGA) (arg-
425-stop codon) and predicted a truncated protein. No other
mutations were found in the remaining exons of gene Zdhhc13 or in
Table 1. Structural parameters for trabecular bone.
Mouse genotype Wild type (+/+) Affected (2/2)
BV/TV (%) 9.5863.22 2.9661.21**
Tb.Th (mm) 0.0760.01 0.0760.002
Tb.Sp (mm) 0.4460.03 0.660.11
Tb.N (1/mm) 1.3760.33 0.4560.18**
SMI 0.6960.3 1.4460.25**
BMD (g/cm
3) 0.5360.003 0.4260.02**
**P,0.01 BV, trabecular bone TV, tissue volume; Tb.Th, trabecular thickness;
Tb.Sp, trabecular separation; Tb.N, trabecular number; SMI, structure model
index; BMD, bone mineral density.
doi:10.1371/journal.pgen.1000985.t001
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region were also normal without detectable mutations.
Real time RT-PCR showed that the tissue expression of Zdhhc13
mRNA was significantly reduced to 26.23% in the liver and 15.59%
inthekidneyoftheaffectedmicecomparedtothewildtype,(Table3).
The decreased mRNA indicated nonsense RNA decay due to the
premature stop codon in our mutant Zdhhc13 mice.
To confirm that we had identified the correct gene, we obtained
a gene trap allele in Zdhhc13 from the SIGTR. This allele
produced the same phenotype as the ENU-induced allele, with the
Figure 4. Skin histopathology of the affected mice. Skin of an affected mouse at age 16 weeks showed hyperkeratosis (arrow) and hyperplasia
of the epidermis and thin dermis layer with scanty subcutaneous adipose tissue (A) when compared to a wild-type mouse (B). The hair follicles
contained no hair shafts and their upper portions were dilated and filled with keratinized materials in a mutant mouse (C) as compared to the normal
hair follicles in a wild-type mouse (D). (H&E, Bar=200 mm in A and B; 100 mm in C and D).
doi:10.1371/journal.pgen.1000985.g004
Figure 5. Histopathology analysis of amyloid in skin of an affected mouse. Skin sections were stained with H&E (A) and Congo red (B); and
the latter stained section was also observed using a polarizing microscope (C). Note that amyloid deposits appeared eosinophilic by H&E stain, pink-
red in Congo red stain, and showed yellow-green birefringence under a polarizing microscope.
doi:10.1371/journal.pgen.1000985.g005
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with the closely linked Oca2 locus carried in the 129/Ola gene trap
ES cells. The skin which showed abnormal hair follicles, lack of
hair and thickened epidermis (Figure 9E) which are similar to the
mutant mice identified by the ENU mutation.
Expression of Zdhhc13
We carried out Northern analysis of a variety of tissues to
determine where Zdhhc13 is expressed. We found that Zdhhc13 is
expressed in most adult tissues, but at low levels in the liver, skin,
and lung (Figure 9A). We hypothesized that Zdhhc13 may be
needed most during development of these tissues, so we analyzed
expression of Zdhhc13 in liver, skin, lung and brain at three
different time points: postnatal day (P) 2, P8 and P30. Zdhhc13 was
expressed most highly in the liver, lung, and brain at P2, showing
that transcripts are developmentally regulated (Figure 9B). In
contrast, Zdhhc13 is expressed most highly in skin at P8, when hair
follicles are maturing. We examined the gene trap allele, which
contains a lacZ reporter gene, for expression of Zdhhc13 in the skin,
and found that it is expressed in the epithelium surrounding the
hair follicles, consistent with a role in hair growth (Figure 9).
Mutation in Zdhhc13 Affects Protein Palmitoylation
Huntingtin is a known substrate of Zdhhc13 [11]. To
demonstrate the palmitoylation defect caused by the mutation,
HEK 293 T cells were co-transfected with huntingtin-myc and
Zdhhc13-flag (WT and mutant). We examined the palmitoylation
levels using acyl-biotin exchange assay after immunoprecipitation
of huntingtin with anti-myc antibody and found that the
huntingtin was palmitoylated by the wild-type Zdhhc13. The
ability of mutant Zdhhc13 to palmitoylate huntingtin was greatly
reduced by the mutant Zdhhc13, to a level indistinguishable from
the endogenous palmitoyl activity present in the control
(Figure 10A).
Moreover, when we examined the IgG light chain purified from
serum of wild and mutant mice, we observed much less
Table 2. Distributions and amyloid type in various tissues of the affected mice using Congo-Red Stain and immunohistochemistry.
Organ Tissue 2/2 age(24±1.85) (n=10)* 2/2 4 weeks (n=2)
CR AA ALl ALk CR AA ALl ALk
Liver Sinusoid ++ ++ + ++ + - 66
portal vein ++ ++ + ++ + ---
central vein ++ 6 - 6 ----
spleen red Pulp +++++- 66
white Pulp ++ ---+ ---
central artery ++ 666----
kidney glomerulus + + +++ + ++++
Tubules ++ + + ++ + - 6 -
perivascular tissue ++66----
Skin hair follicle + ---+ ---
dermis and epidermis ++ ++ ++ + + 666
subcutaneous tissue ++++- 666
Adrenal gland Cortex ++ ---6 ND ND ND
Medulla ++ ++ - ++ -N D N D N D
Pancreas Acini ++ ND ND ND 6 ND ND ND
Islets of Langerhans ++ ND ND ND 6 ND ND ND
perivascular tissue + ND ND ND 6 ND ND ND
Salivary gland acini cells ++ ND ND ND + ND ND ND
blood vessel wall ++ ND ND ND + ND ND ND
Heart cardiac myocyte ++66----
perivascular tissue ++ + 6 + ----
Lung Alveoli + ND ND ND - ND ND ND
perivascular tissue + ND ND ND - ND ND ND
Intestine Velli + 666----
lamina properia + 666----
perivascular tissue + 666----
Brain Cerebellum + -------
perivascular tissue + -------
Cerebrum 6 -------
Bone bone marrow 6 ND ND ND - ND ND ND
Muscle myofibril - ND ND ND - ND ND ND
(* Zdhhc13
2/2 adult mean age, (mean6SE) week, (- negative, 6 Uncertainty + mild, ++ severe ND: not done).
doi:10.1371/journal.pgen.1000985.t002
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PLoS Genetics | www.plosgenetics.org 6 June 2010 | Volume 6 | Issue 6 | e1000985Figure 6. Histopathological analysis of amyloids in different organs of the affected mice. Amyloid deposition in sinusoids and around the
portal vein in liver (A); in red pulp and peri-white pulp area in spleen (B). In kidney, amyloid was found in glomerulus (C) and renal tubules (D).
Amyloid was also found in adrenal cortex and medulla (E), islet of Langerhans and around the acinar cells of pancreas (F), salivary glands (G) and
myocardium (arrows in H). All sections were stained with Congo red; amyloid deposits appeared pink-red color with this staining. Bar=100 mm.
doi:10.1371/journal.pgen.1000985.g006
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type mice (Figure 10C).
Discussion
Using ENU-mutagenesis, we have identified mice with severe
phenotypes manifested by failure to thrive, alopecia, osteoporosis,
systemic amyloidosis and early death. We found that a nonsense
mutation (R425X) in Zdhhc13 was the cause of these abnormal
phenotypes. To ensure that other mutations induced by ENU
would not confound the observed phenotypes, mice examined
after 6 generations of outcross breeding continued to show 100%
phenotype and genotype correlations [14]. Further, a gene trap
allele of Zdhhc13, which contains a vector inserted into the first
intron, exhibits the similar phenotypes (data not shown).
Zdhhc13, also named huntingtin-interacting protein-like
(HIP14L), shares 51% identity and 69% similarity with hunting-
tin-interacting protein-14 (HIP14) or Zdhhc17 between #45 and
#611 of the 622 residues [15]. Both Zdhhc13 and 17 belong to a
family of enzymes that are involved in attaching lipids to proteins,
Figure 7. Immunohistochemistry of amyloidosis in affected mice. Immunohistochemistry analysis of amyloids in liver (upper panel) and in
kidney (lower panel) of an affected mouse. Antibodies against AA amyloid (AA), k light chain (ALk), and l light chain (AL l) were used to differentiate
types of amyloid; note progressively increase of amyloid deposition with age. Bar=50 mm.
doi:10.1371/journal.pgen.1000985.g007
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a PAT, is also a mediator of Mg
2+ transport. Inhibition of
palmitoylation by 2-bromopalmitate (2BP) diminished Mg
2+
transport by about 50% [16]. The causal mutation (R425X) in
Zdhhc13 mice would predict the synthesis of a truncated protein
lacking the zinc-finger DHHC-CRD domain (#426-476) and the
active site (C456) for the formation of an S-palmitoyl cysteine
intermediate (Figure S1). Thus, it is unlikely that this truncated
protein can perform any palmitoylation function, consistent with
the similarity of phenotypes with the gene trap allele. Because our
mutant mice had normal serum magnesium and calcium levels
and demonstrated no clinical evidence of magnesium deficiency,
we propose that the observed phenotypes originated from the loss
of the enzymatic function of Zdhhc13 as a PAT. Indeed, we have
shown that mutation in the Zdhhc13 affects the protein
palmitoylation.
The exact mechanism by which the mutation of Zdhhc13
resulted in such diverse pathologies is not clear. Amyloidosis is a
devastating group of disorders in which normally soluble proteins
are misfolded and aggregate to form insoluble amyloid fibrils with
Figure 8. Mapping and molecular analyses of the gene responsible for the phenotypes. (A) Whole chromosomal mapping using 295 SNP
markers. High homozygosity region is circled comprised of consecutive SNPs between SNP rs30814649 (46468726 bp) to SNP rs32491610
(64723695 bp) on chromosome 7. (B) Fine mapping of the candidate region using 52 SNPs on chromosome 7. Complete homozygosity is located
between rs32116930 (53918742 bp) and rs32209625 (56317368 bp) (circled area). (C) DNA sequence analysis of mouse Zdhhc13 gene. Nucleotide
sequences in exon 12 showing that affected mouse was homozygous for T at position c.1273 (arrow); unaffected parent was heterozygous A/T and
wild-type was A/A at the same position.
doi:10.1371/journal.pgen.1000985.g008
Table 3. Real-time quantitative RT–PCR of Zdhhc13 mRNA in mouse tissues.
Tissue Liver Kidney
mRNA Control ±SD Affected ±SD Control ±SD Affected ±SD
Ct
1 (Zdhh13) 24.7560.11 27.1560.18 23.260.24 25.1160.21
Ct
1 (B-actin) 20.5560.39 20.8560.16 20.4360.34 19.6660.21
DCt
2 4.3760.13 6.360.09 2.7760.11 5.4560.04
DDCt
3 0 1.93 0 2.68
2
(DDCt) 4 100% 26.23% 100% 15.59%
1 Ct, cycle threshold. Values represent triplicates of 3 wild type and 3 affected animals.
2 DCt=Ct (Zdhhc13)- Ct (B-actin).
3 DDCt=DCt (Affected) - DCt (Control).
4 2
(DDCt) represents relative expression level of Zdhhc13 in affected mouse tissues as compared to control.
doi:10.1371/journal.pgen.1000985.t003
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response (UPR) and its downstream pathways, including autoph-
agy and cell death by apoptosis [17-19]. There are two major types
of systemic amyloidosis. AA-amyloidosis, also called secondary or
reactive amyloidosis, is a consequence of prolonged high level
expression, mainly in the liver, of the acute-phase protein Serum
Amyloid A precursor protein (SAA). AA-amyloidosis is usually
associated with chronic inflammatory conditions but it can also be
caused by mutations in a constitutively expressed protein, resulting
in its greater tendency to aggregate [20,21]. The second type of
amyloidosis is called AL-amyloidosis. It is either a primary or a
multiple myeloma-associated amyloidosis; its fibrils are derived
from fragments of monoclonal immunoglobulin light chain (l and
k) condensed into b-pleated sheet structures as a result of
incomplete breakdown in the autophagolysosomes [22]. It is rare
to find both AA and AL types in the same patient, and such cases
only account for ,2–3% of all amyloidosis patients [23].
Our Zdhhc13 mutant mice manifested both AA and AL amyloids
(Figure5,Figure 6,Figure 7).Liver,spleen,kidneys,skin,adrenaland
salivary glands are the most affected organs resulting in hepato-
splenomegaly, nephromegaly, sialadenosis (non-inflammatory swell-
ing of the salivary glands) and skin involvement. We cannot attribute
this observed amyloidosis to inflammation, as CRP levels were
normal (Table S2). Nor can we attribute it to multiple myeloma, as
blood and bone marrow contained no excess plasma cells (data not
shown). Furthermore, sequences of all amyloid-related genes in the
candidate regions were normal except for the single mutation
(R425X) in Zdhhc13. The coexistence of AL and AA systemic
amyloidosis could be attributed to the fact that the presence of AL
type amyloid fibrils acting as an amyloid-enhancing factor (AEF) and
enhance the AA amyloid deposition [23–26]. Alternatively, a
deficiency of Zdhhc13 may play a role in the amyloidogenesis.
Palmitoylation is known to affect protein stability by influencing a
protein’s access to an ubiquitinating enzyme [27]. Palmitoylation is
Figure 9. Expression of Zdhhc13. (A) Expression of Zdhhc13 in normal adult tissues. GAPDH was used as a loading control, (B) Expression of
Zdhhc13 in liver, skin, lung and brain at postnatal (P) days 2, 8, and 30. Again, GAPDH was used as a control, (C) A gene trap vector insertion in intron
1o fZdhhc13. The open arrow containing a b-geo cassette indicates the location of the gene trap vector, (D) Xgal staining of the p10 gene trap
mutant and wild type. Note protein expression in the epithelium of the hair follicles. Sections were counterstained with nuclear fast red. The
magnification is 2006, (E) Histopathology of gene traps mice skin, showing the abnormal follicles, lack of hair and thickened epidermis which are
similar to ENU mutant mice.
doi:10.1371/journal.pgen.1000985.g009
Model of Zdhhc13 Mutation Causing Severe Phenotype
PLoS Genetics | www.plosgenetics.org 10 June 2010 | Volume 6 | Issue 6 | e1000985also known to protect huntingtin from aggregation [28], and prevent
oligomerization of certain proteins [29]. Moreover, defective
palmitoylation results in aggregation of amyloid b-sheet, which leads
to the formation of fibril [30].
Therefore, we propose that a deficiency of Zdhhc13 PAT activity
may have caused amyloidosis in our mice. The lack of Zdhhc13
PAT activity affected palmitoylation of a set of unspecified protein
targets and compromised their conformational stability and
subcellular localization, eventually causing systemic amyloidosis
of both the AA and AL types [26]. Coincidentally, a computer
algorithm predicted the presence of palmitoylation site(s) on both
SAA and the light chains of IgG [31]. Consistent with this notion
was our demonstration of reduced level of palmitoylation of IgG
light chain in the mutant mice.
Deficiency of protein palmitoylation in the Zdhhc13 mutant mice
could also explain the apparent osteoporosis because palmitoyla-
tion regulates osteoblast differentiation through bone morphogen-
esis protein (BMP)-induced Osterix expression [6]. Deletion of
Osterix leads to a loss of mature osteoblasts and a lack of calcified
bones (Osteoporosis), other signaling pathways such as NF-kB may
be also involved in the development of the severe osteoporosis
phenotype observed as early as weaning [32].
The Zdhhc13 mutant mice also showed significant skin
pathology with hypotrichosis, alopecia and loose skin with
wrinkling and folding. Histopathology revealed epidermal hyper-
plasia with a thin dermis, inactive hair follicles and amyloid
deposition. Expression analysis shows that expression of Zdhhc13 is
upregulated at the time of follicle maturation (P8), consistent with
Figure 10. Palmitoyl-acyl transferase (PAT) activity and IgG light chain palmitoylation in the wild-type and mutant mice. (A) Acyl-
biotin exchange assay showing palmitoylation of huntingtin (Htt) was greatly reduced by the mutant Zdhhc13 as compared to the wild type in the
hydroxylamine (NH2OH)-treated group. Low panel was a loading control for huntingtin. Wt: wild Zdhhc13, Mut: mutant Zdhhc13, C: Control: cells
transfected with huntingtin alone without co-transfection with Zdhhc13. WB: western blot, (B) HEK 293T cells co-transfected with huntingtin and
Zdhhc13 showing expression of these proteins was approximately even, (C) Levels of IgG light chain palmitoylation in the wild-type and mutant mice.
IgG light chain purified from serum of the wild and mutant mice were labeled with S-palmitoylation using acyl-biotin exchange method. IgG light
chain treated with hydroxylamine showed reduced palmitoylated signals in mutant mice as compared to the wild type (p=0.001, n=3, t test). Low
panel was a loading control.
doi:10.1371/journal.pgen.1000985.g010
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molecular mechanisms are not clear, these phenotypes are
consistent with defects in the NF-kB signaling pathways [33].
Another possible mechanism responsible for the skin pathology is
the BMP-induced MAPK pathway as protein palmitoylation plays
an important role in BMP-induced MAPK pathway activation [6].
BMP is involved not only in osteoblast differentiation but also in
epidermal proliferation and differentiation, hair follicle cycling and
innervations [34]. Since Zdhhc13 normally upregulates both NF-
kB and MAPK signaling pathways [35] the Zdhhc13 mutation may
significantly affect these pathways, leading to the disease
phenotypes.
In summary, we report that deficiency of a single palmitoyl
acyltransferase (Zdhhc13) can cause severe systemic phenotypes,
including failure to thrive, cachexia, osteoporosis, alopecia, multi-
organs/systems dysfunction secondary to systemic amyloidosis and
early death. Our results established a direct link between protein
palmitoylation and regulation of important diverse physiological
functions and indicated that its absence can result in profound
disease pathology. This mouse model will be useful for further
investigation of the mechanisms by which improper palmitoylation
leads to disease processes. The identification of target proteins of
ZDHHC13 would be an important first step for understanding the
molecular mechanisms underlying human alopecia, osteoporosis
and many neurodegenerative diseases caused by protein misfold-
ing and amyloidosis.
Materials and Methods
Mouse Lines
The first recessive mutant allele was generated by a
conventional ENU mutagenesis regimen. [36]. Briefly, multiple
doses of N-ethyl-N-nitrosourea (ENU) (100 mg per kg body
weight) were injected to mutagenize spermatogonia of C57BL/6J
males (G0 generation). Recessive mutations were isolated in the
third generation of breeding to females that carried either the
balancer chromosome 129S6.Inv(11)8Brd or 129.Rex mutations,
both of which had been made congenic on a 129S6/SvEvTac
genetic background (N=10). The mutant mice reported here
were identified by their small size and hypotrichosis as early as
postnatal day 7 and were designated as skin and coat mutation 4
(skcm
04Jus). The mutant line was inherited as a recessive trait that
segregated independently of the chromosome 11 balancer and the
phenotype was completely penetrant in the 129S6/SvEv genetic
background, and, later on, in the C3H background. The
experimental protocols in this study were reviewed and approved
by the Institutional Animal Care and Utilization Committee of
Academia Sinica.
The gene trap allele was produced from embryonic stem (ES)
cells AC0492 obtained from the Sanger Institute Gene Trap
Resource (SIGTR). ES cells were injected into C57BL/6J
blastocysts by the Darwin Genetics Core at Baylor College of
Medicine. Chimeras were obtained, mated to C57BL/6J mice,
and the allele was transmitted through the germline to generate
Zdhhc13
SIGTR mice. Subsequent experiments were performed on
mice from this mixed 129/B6 genetic background. After initial
genotyping of ES cells for the gene trap allele per protocols
available from the resource, the phenotype was used to follow
transmission of the allele. Zdhhc13 is located at 56 Mb on
Chromosome 7, which is only 7 Mb from Oculocutaneous
albinism 2 (Oca2; pink-eyed dilution), which is located at 63 Mb.
Therefore, mice carrying the gene trap allele were also pink-eyed
and had dilute coat colors because of the Oca2 mutation carried in
the 129/Ola ES cells used to generate the gene trap.
Blood Chemistry
Blood samples were obtained through an incision of the tail
artery or by cardiac puncture at the time of sacrifice and collected
in a heparinized tube (MICROTAINER, BD Diagnostics,
Franklin Lakes, NJ). Complete hemogram was carried out using
Abbott Cell-DYN 3700 Veterinary Haematology Analyzer
(Abbott Laboratory, Illinois, USA). Thin blood smears were
taken directly from the tail artery, fixed with absolute methanol
for 5 minutes and stained by modified Wright’s Giemsa stain for
Plasma cells (Plasma B cells) identification. Plasma was analyzed
using the FUJI DRI-CHEM SYSTEM 3500s (Fuji Photo Film
Co. Ltd.) for measurement of aspartate aminotransferase (AST;
U/l), alanine aminotransferase (ALT; U/l), creatinine phospho-
kinase (CPK; U/l), total cholesterol (TCHO; mg/dl), total
protein (TP; g/dl), albumin (ALB; g/dl), globulin (GLO; g/dl),
total bilirubin (TBIL; mg/d), blood urea nitrogen (BUN; mg/dl),
C-reactive protein (CRP; mg/dl), calcium (Ca; g/dl) and
magnesium (Mg; g/dl).
Micro-Computed Tomography (Micro–CT) Analysis of
Bone
For trabecular bone analysis and 3D images, a micro-CT
scanner (Skyscan-1076, Skyscan, Belgium) was operated at 50 kV,
200 uA, 0.4u of rotation step, 0.5 mm Al filter and 9 um/pixel of
scan resolution. For bone mineral density (BMD) analysis, it was
operated at 50KV, 200 uA,1 u of rotation step, 0.5 mm Al filter
and 35 um/pixel of scan resolution. Cross-sections were recon-
structed using a cone-beam algorithm (software Cone_rec;
Skyscan, Belgium). Files were then imported into CTAn software
(Skyscan) for three-dimensional analysis and three-dimensional
image generation. BMD for each femur was measured by CTAn,
which was calibrated using of phantoms with known BMD
(0.25,0.75 g/cm
3).
Histopathology
Mice were sacrificed with overdoses of sodium pentobarbital for
the histop-athological examinations. After flushing with normal
saline, mice were perfused through the heart with 4% parafor-
maldehyde in 0.1M PBS, pH7.4, the perfusion flow rate, (4 ml/
min) was controlled by an infusion pump (Bio-Rad, Econo Pump).
A total of 37 organs and tissues, including heart, lung, liver,
kidney, spleen, pancreas, adrenal gland, salivary gland, brain, skin,
adipose tissues, skeletal muscles and bone, were removed,
embedded in paraffin, cut into 5 mm sections and stained with
hematoxylin-eosin (H&E) for general pathological examinations.
Other serial sections were also processed for Congo Red staining
to detect amyloid; and immunohistochemistry staining for amyloid
classification. Bone marrow was aspirated from both femora for
bone marrow smears immediately after sacrificing by cervical
vertebral dislocation. Smears were fixed with absolute ethanol for
5 minutes and stained by modified Wright’s Giemsa stain for
Plasma cells identification.
Immunohistochemistry
Immunostaining used the following antibodies: rabbit anti-
human l light chains polyclonal antibody, rabbit anti-human k
light chains polyclonal antibody, mouse anti-human amyloid A
monoclonal antibody (DakoCytomation). Tissue sections were
pretreated with concentrated formic acid for 1 min, washed in tris-
buffered saline (TBS) for 10 min, then incubated in Rodent Block
M (BioCare) or tris-buffered saline Tween (TBST) containing 2%
bovine serum albumin and 3% normal goat serum at 37uC for
30 min. Then, tissue sections were incubated with primary
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room temperature and then washed again in TBST followed by
incubation with horseradish peroxidase-conjugated secondary
antibody (anti-rabbit IgG and goat anti-mouse IgG (Jackson
ImmunoResearch. West Grove, USA). Color was developed with
0.1% 3,39-diaminobenzidine.
Mapping of Gene Responsible for Abnormal Phenotypes
For the purpose of rough mapping, the affected skcm
04Jus mice,
which were in a mixed 129S6/SvEv and C57BL/6 mixed genetic
background at the N=4 generation on 129S6/SvEvTac
(obtained from Baylor College of Medicine) were outcrossed to
the C3He/HeJ strain in Academia Sinica to generate N1
offspring, and N1 mice were then intercrossed with generate
N1F1 offspring. DNA was collected from 32 affected N1F1 mice.
A panel of 295 single nucleotide polymorphism (SNP) markers
located on all 19 mouse autosomes and the X-chromosome for
mouse strains C3H/HeJ, C57BL/6, DBA/2J or BALB/cByJ was
selected from a SNP dataset containing 10,915 SNPs from 48
mouse strains (provided by Tim Wiltshire, Genomics Institute of
the Novartis Research Foundation, San Diego, California). SNPs
were chosen based on the criterion that the genotype of these
strains at the 295 loci was different from that of C57BL/6J. Since
point mutations were introduced into C57BL/6J genome by
ENU, the recessive mutant phenotype will always associated with
a homozygous B6 SNP genotype at the mutant locus. SNP
genotyping using genomic DNA isolated from mouse tails
(Puregene DNA purification kit, Gentra Systems, Minneapolis,
MN, USA) was performed using high-throughput MALDI-TOF
mass spectrometry [37,38]. Primers and probes flanking the SNPs
were designed in multiplex format using SpectroDESIGNER
software (Sequenom, San Diego, CA, USA). PCRs were
performed in a volume of 5 ml containing 0.15 U of Taq
polymerase (HotStarTaq, Qiagen, Valencia, CA, and USA),
5.0 ng of genomic DNA, 1.0 pmol of each PCR primer and
2.5 nmol of dNTP. Thermocycling conditions were one cycle at
94uC for 15 min, 45 cycles of 94uC for 20 s, 56uC for 30 s, 72uC
for 30 s and one final cycle of extension at 72uC for 3 min.
Unincorporated dNTPs were dephosphorylated using 0.3 U of
Shrimp Alkaline Phosphatase (Hoffman-LaRoche, Basel, Swit-
zerland) followed by primer extension using 9 pmol of each
primer extension probe, 4.5 nmole of the appropriate dNTP/
ddNTP combination, and 1.28 U of Thermosequenase (Amer-
sham Pharmacia, Piscataway, NJ, USA). Reactions were cycled at
94uC for 2 min, followed by 55 cycles of 94uCf o r5s ,5 2 uCf o r
5 s and 72uC for 5 s. Following the addition of a cation exchange
resin (SpectroCLEAN, Sequenom) to remove residual salt from
the reactions, 15 nl of the purified primer extension reaction was
spotted onto a 384-element silicon chip preloaded with 3-
hydroxypicoloinic acid matrix (SpectroCHIP, Sequenom), using
the SpectroPOINT (Sequenom). SpectroCHIPs were analyzed
using a Bruker Biflex III MALDI-TOF SpectroREADER mass
spectrometer (Sequenom) and spectra processed with Spectro-
TYPER (Sequenom).
For fine mapping, 52 SNPs covering the candidate region from
46468726 bp (SNP rs30814649) to 64723695 bp (SNP rs32491610)
on chromosome 7 (Mouse Genomic Informatics (MGI) http://
www.informatics.jax.org/javawi2/servlet/WIFetch?page=snpQF were
selected. Strain C57BL/6 was used as a selected strain and C3He/HeJ
and 129/SvEv as reference strains. DNA samples from 84 affected N1F1
mice and 10 parental heterozygous mice in a 96 well plate (MicroAmp
Optical 96-Well Reaction Plate, Applied Biosystems)w e r eu s e df o rS N P
genotyping using high-throughput MALDI-TOF mass spectrometry.
Identification of the Mutant Gene
All exons, exon-intron junctions and 2.5 kb promoter regions of
candidate genes, Saa11, Saa3, Saa4, Saa1, Saa2 and Zdhhc13, were
amplified and sequenced. Primers were designed using
the Primer3 program http://biotools.umassmed.edu/bioapps/
primer3_www.cgi. The primers used for the detection of an exon
12 mutation in the Zdhhc13 gene were F, 59-CTGGGTTGA-
GAGTATTCCACA-39 and R, 59-GAGATTAGCCACA-
GAGCTTCG-39. PCR reactions were performed in a final
volume of 25 ml, containing 50 pmol of each primer (0.5 ul),
106 Taq Buffer (10 mM Tris–HCl (pH 8.3), 50 mM KCl) with
1.5 mM MgCl2 (2.5 ul), 2.5 mM dNTPs (2.5 ul) and Taq DNA
polymerase (5 U/ul) MDBio, Inc. (0.25 ul). Amplification condi-
tions were an initial denaturation of 4 min. at 94uC, followed by
20 cycles of touchdown PCR in 30 s at 94uC, 30 s at 65uC
(decrease 0.5uC per cycle), 40 s at 72uC; and a final 20 cycles in
30 s at 94uC, 30 s at 55uC, followed by 40 s at 72uC and then a
final extension at 72uC for 5 min. All amplified PCR fragments
were digested with shrimp alkaline phosphatase and ExoIt o
remove unincorporated primers and sequenced using the BigDye
Terminator Cycle Sequencing Kit v1.1/3.1 (Applied Biosystems,
Foster City, CA, USA) following the manufacturer’s instructions.
Sequencing products were separated on either ABI PRISM 3100
Genetic Analyzer or ABI PRISM 3700 DNA Analyzer (Applied
Biosystems). Raw sequencing data were analyzed with the DNA
Sequencing Analysis Software v3.7 (Applied Biosystems).
Expression Analysis
To examine the differences in the tissue expression of Zdhhc13,
total RNA samples were extracted from liver and kidney of three
6-month old mutants as well as three aged-matched wild type
C3He/HeJ mice using Trizol following the manufacturer’s
protocol. First-strand cDNA was synthesized using 1 ml oligo-dT
15 primer and 1 ml SuperScript III RT (200 U/1 ml) in 20 ml
volume of 2 mg of total RNA, 1 ml of 10 mM dNTPs, 1 mlo f
reaction buffer (10 mM Tris-HCl pH 8.3, 2.5 mM KCl, 0.6 mM
MgCl2), ml of RNase inhibitor40 U/ml, and 1 ml of 0.1 M DTT.
Real-time quantitative RT-PCR analysis used the ABI PRISM
7700 Sequence Detection System (Applied Biosystems). RT-PCR
amplification of Zdhhc13 was carried out using the following
primer set: 59- GACTGGACGCTGCATAGGTT, forward
strand in Zdhhc13 exon13, and 59- TGGCACAATGATTTGAC-
CAG, reverse strand in Zdhhc13 exon 15. The primers were
designed using Primer Express (Applied Biosystems).
The cDNA corresponding to 75 ng of reversed transcribed total
RNA was amplified in a final volume of 20ml using Power SYBER
green PCR Master mix in 20ml total reaction volume in duplicate
assays for Zdhhc13 and endogenous B-actin as an internal control.
An analysis of the results was based on the Ct calculation, where
Ct represents the cycle number at which fluorescence of the PCR
samples crossed a given threshold. The expression level of b-actin
was taken as the first ‘‘calibrator’’ to normalize the total Zdhhc13
mRNA in each tissue (DCt). Expression of, Zdhhc13 in each of the
control mouse tissue was then taken as the second ‘‘calibrator’’ to
normalize the expression of Zdhhc13 in the affected tissue
accordingly (DDCt). Final results were given as the relative
amounts of Zdhhc13 mRNA in the affected mouse tissues as
compared to the control (2
DDCt).
Northern analysis was carried out as previously described by
Lorenzetti et al. [39], using 10 ug of total RNA isolated using RNA
STAT-60 reagent (TEL-TEST, Inc., Friendswood, TX) according
to the manufacturer’s protocol, and transferred to a nylon
membrane. The blot was hybridized using Ultrahyb (Ambion)
with a probe for Zdhhc13 is the N-terminal 571 base pairs, which
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GGCCCGGGCCT-39, R-59-TAAGCCGATAGCATGAGCG-
39). The probe for GAPDH is the N-terminal 509 base pairs,
which was PCR amplified with two primers (F-59-
GGTCGGTGTGAACGGATTTGG-39, R-59-CATGAGCC-
CTTCCACAATGCC-39). [39] B-galactosidase staining was
carried out using X-gal staining, the skins of p1, p6 and p10 mice
were embedded in Tissue Tek and frozen after fixation with 4%
paraformaldehyde and sucrose protection. The 10 mm vertical
cryosections were fixed again in 2% paraformaldehyde followed
by serial washing (three times washing with 2 mM MgCl2
containing PBS, 0.02% NP40 and 0.01% deoxycholate). The
sections were pre-incubated with the staining buffer (PBS
supplemented with 5 mM K3Fe(CN)6, 5 mM K3Fe(CN)6,2m M
MgCl2) for 2 min, and further incubated with the staining buffer
supplemented with 1 mg/ml Xgal for 3 hrs. After washing with
PBS, the sections were counterstained with Nuclear Fast Red
(Vector) and then mounted.
Evaluation of Enzyme Activity of Zdhhc13
We used huntingtin, a known substrate for Zdhhc13, and acyl-
biotin exchange assay [11] to measure the palmitoyl acyl
transferase activity. Plasmid construction: The cDNA of wild type
and mutant Zdhhc13 were subcloned into C-terminal p3xFLAG-
CMV vector (Sigma). Huntingtin (1–548 aa) cDNA was
subscloned into pcDNA4/myc-His (Invitrogen). Cell culture:
HEK293T cell were used for transiently transfected with
Lipofectamine 2000 (Invitrogen). At 24–48 hours posttransfection,
cells were harvested with PBS and proteins were extracted with
lysis buffer (LB, 150 mM NaCl, 50 mM Tris-HCl, 5 mM EDTA,
1 mM PMSF, 1X protease inhibitor (Roche), 0.2% Triton X-100,
pH 7.4) containing 50 mM N-ethylmaleimide (NEM) (Sigma).
Immunoprecipitation (IP) and immunobloting (IB) of huntingtin
protein and acyl-biotin exchange assay to label S-palmitoylated
protein were performed using Myc antibody (Invitrogen), 1:250 for
IP; 1:5000 for IB; and FLAG, mouse, antibody (Sigma) 1:2000 for
IB; as described previously [11].
IgG Light Chains Purification and the Evaluation of S-
Palmitoylation
Serum from 5 month old mice was used to purify the IgG light
chain. Serum was incubated with Protein A/G agarose beads
(Santa Cruze Biotechnology) for 1 hour at room temperature.
After washing the beads with PBS for 3 times, IgG light chain were
eluted with 0.2 M Glycine (pH 2.5) and neutralized with 1M Tris-
HCl (pH 8.5). The eluted fractions were precipitated using the
chloroform/methanol (C/M) precipitation method. Protein pellets
were redissolved with 4% SDS buffer (50 mM Tris-HCl, 4% SDS,
5 mM EDTA, pH 7.4) containing 50 mM N-ethylmaleimide
(NEM) (Sigma) for 10 minutes at 37uC. Following dilution with
3 vol of lysis buffer, the fraction was rotated end-over-end
overnight at 4uC. Excess NEM was removed with 3 sequential
C/M precipitations. Protein pellets were redissolved with 4% SDS
buffer and divided to 2 portions. First portion was added to 3 vol of
lysis buffer containing 1 M hydroxylamine, pH 7.2 and incubate
for 1 hour at room temperature to remove palmitate group from
the protein. Control portion was in lysis buffer without
hydroxylamine. After incubation, 3 sequential C/M precipitations
were performed on samples to remove hydroxylamine. Protein
pellets were redissolved with 4% SDS buffer and were added with
3 vol of lysis buffer containing 0.5 mM biotin-BMCC (Pierce),
pH 6.2 and incubate for 1 hour at 4uC to label the protein,
followed by SDS-PAGE and Western blotting. Streptavidin
protein- HRP (abcam) was used against biotinylated protein.
Rabbit anti-human k light chain polyclonal antibody (DakoCyto-
mation) was used against IgG light chain.
Supporting Information
Figure S1 Predicted secondary structure of Zdhhc13 (Huntingtin-
interacting protein 14-related protein, HIP14-related protein a
palmitoyltransferase ZDHHC13). ZDHHC is 660 AA with molec-
ular weight of 70890 Da, it has 6 transmembrane domains and 6
ANK repeats (ANK 1–6), Zn_Fing (DHHC-TYPE) length is 51aa
(from 426–476aa) and the Bompbias (Phe-rich) is 64aa (from 328–
391aa). The active site (S-palmitoyl cysteine intermediate) is located
at residue 456. Note that nonsense mutation arg-425-stop codon is
located before both Zn_Fing and the active site of the protein.
Found at: doi:10.1371/journal.pgen.1000985.s001 (0.10 MB TIF)
Table S1 Peripheral blood complete blood counts in affected
and wild-type mice.
Found at: doi:10.1371/journal.pgen.1000985.s002 (0.05 MB
RTF)
Table S2 Blood chemistry in affected and wild-type mice.
Found at: doi:10.1371/journal.pgen.1000985.s003 (0.05 MB
RTF)
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